Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole genome sequencing and analysis of Streptococcus agalactiae samples collected in Malawi

PROVIDER: PRJEB8986 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1910510_1.fastq.gz	Fastqsanger.gz
	ERR1910510_2.fastq.gz	Fastqsanger.gz
	ERR1910520_1.fastq.gz	Fastqsanger.gz
	ERR1910520_2.fastq.gz	Fastqsanger.gz
	ERR1910530_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 758

Similar Datasets

Project description:Whole genome sequencing and analysis of Streptococcus agalactiae samples collected in Ireland

| PRJEB26339 | ENA

Streptococcus agalactiae stringent response RNA-seq

Project description:Transcriptome analysis of Streptococcus agalactiae (group B Streptococcus) grown under control conditions or coincubated with serine hydroxamate to induce the bacterial stringent response

2017-11-14 | GSE98398 | GEO

Streptococcus agalactiae CJB111 isolate:CJB111

Project description:Streptococcus agalactiae whole genome sequencing

| PRJNA663970 | ENA

Streptococcus agalactiae

Project description:Streptococcus agalactiae Whole Genome Sequencing

| PRJNA649379 | ENA

Streptococcus agalactiae strain:not collected | isolate:not collected

Project description:Streptococcus agalactiae strain:not collected | isolate:not collected Genome sequencing

| PRJNA611468 | ENA

The Streptococcus agalactiae transcriptional landscape

Project description:Streptococcus agalactiae, also known as Group B streptococcus, emerged in the 1960s as a leading cause of septicemia and meningitis in neonates. It is also an increasing cause of infections in adults with underlying diseases. To characterize regulatory elements in this species we performed a genome-wide transcription start site (TSS) profiling and whole-transcript sequencing. TSS were identified by using a differential RNA-seq strategy, based on selective Tobacco Acid Pyrophosphatase (TAP) treatment and adapter ligation, which differentiates primary transcripts and processed RNAs. The accuracy and sensitivity of TSS identification were increased by combining differential RNA-seq analyses under eight conditions corresponding to variations in growth conditions and genetic backgrounds. Whole-transcript sequencing used a two-step adaptor ligation-based directional RNA-seq protocol and was performed under two experimental conditions with triplicate experiments to assess variations in gene expression in response to an acid stress

2015-04-21 | E-MTAB-3200 | biostudies-arrayexpress

Project description:Whole Genome Streptococcus agalactiae

| PRJNA1150396 | ENA

GBS_Proteomics

Project description:Proteomics of Streptococcus agalactiae strain COH1

2019-01-30 | MSV000083379 | MassIVE

MuSt multiomics - Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes

Project description:Multiomics of faecal samples collected from individuals in families with multiple cases of type 1 diabetes mellitus (T1DM) over 3 or 4 months. Metagenomic and metatranscriptomic sequencing and metaproteomics were carried out, as well as whole human genome sequencing. Phenotypic data is available.

2016-08-22 | PXD003791 | Pride

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data